Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin L Ricker

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Investigational New Drugs|May 3, 2015
Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignanciesGuillermo Garcia-Manero, Raoul Tibes, Tapan Kadia, et al.
Cancer|July 27, 2012
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaHan Chong Toh, Pei-Jer Chen, Brian I Carr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trialCalin Cainap, Shukui Qin, Wen-Tsung Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2011
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failureNizar M Tannir, Yu-Ning Wong, Christian K Kollmannsberger, et al.
Cancer Discovery|August 14, 2016
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous LeukemiaMarina Konopleva, Daniel A Pollyea, Jalaja Potluri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2011
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancerEng-Huat Tan, Glenwood D Goss, Ravi Salgia, et al.
Blood|October 27, 2007
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromesGuillermo Garcia-Manero, Hui Yang, Carlos Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancerSuresh S Ramalingam, Mikhail Shtivelband, Ross A Soo, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Investigational New Drugs|May 3, 2015
Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignanciesGuillermo Garcia-Manero, Raoul Tibes, Tapan Kadia, et al.
Cancer|July 27, 2012
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaHan Chong Toh, Pei-Jer Chen, Brian I Carr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2014
Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trialCalin Cainap, Shukui Qin, Wen-Tsung Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2011
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failureNizar M Tannir, Yu-Ning Wong, Christian K Kollmannsberger, et al.
Cancer Discovery|August 14, 2016
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous LeukemiaMarina Konopleva, Daniel A Pollyea, Jalaja Potluri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2011
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancerEng-Huat Tan, Glenwood D Goss, Ravi Salgia, et al.
Blood|October 27, 2007
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromesGuillermo Garcia-Manero, Hui Yang, Carlos Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2015
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancerSuresh S Ramalingam, Mikhail Shtivelband, Ross A Soo, et al.
Pageof 3